SCHEMBL24850733

SCHEMBL24850733

CC(=O)N[C@@H](C)C(=O)C(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35
PREP P48147 1/20 0.33
FAP Q12884 1/20 0.33
KDM4E B2RXH2 2/20 0.32
POLB P06746 1/20 0.32
MAPT P10636 1/20 0.32
THRB P10828 1/20 0.32
ALOX15 P16050 1/20 0.32
NFKB1 P19838 1/20 0.32
PTGS2 P35354 1/20 0.32
THPO P40225 1/20 0.32
RECQL P46063 1/20 0.32
BLM P54132 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TRPV1 Q8NER1 1/20 0.31
CA2 P00918 1/20 0.30
PTGS1 P23219 1/20 0.30
MMP12 P39900 1/20 0.30
CYP1A2 P05177 1/20 0.30
ACACB O00763 3/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12247860 1.00 ALDH1A1 (0.35) ALDH1A1PREPFAPKDM4EPOLB
SCHEMBL13543228 1.00 ALDH1A1 (0.35) ALDH1A1PREPFAPKDM4EPOLB
SCHEMBL24263114 0.80 L3MBTL1 (0.39) ALDH1A1KDM4EPOLBMAPTSMN1; SMN2
SCHEMBL13543177 0.78 MAPT (0.35) ALDH1A1POLBMAPTSMN1; SMN2GAA
SCHEMBL12128766 0.78 ALDH1A1 (0.35) ALDH1A1PREPFAPKDM4EMAPT
SCHEMBL8906230 0.76 CA14 (0.33) POLBSMN1; SMN2CA2
SCHEMBL19318523 0.76 CA14 (0.33) POLBSMN1; SMN2CA2
SCHEMBL24850751 0.76 ADAM17 (0.36) ALDH1A1KDM4EPOLBMAPTTHRB
SCHEMBL8907625 0.76 CA14 (0.33) POLBSMN1; SMN2CA2
SCHEMBL18462939 0.75 DPP4 (0.32) ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230025932-A1 NOVEL FUNCTIONALIZED LACTONES AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE PRAEVENTIX, LLC 2023-01-26 US disclosed
US-20230002383-A1 NOVEL FUNCTIONALIZED LACTAMS AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE PRAEVENTIX, LLC 2023-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230025932-A1 NOVEL FUNCTIONALIZED LACTONES AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE HTR7, HTR2C, HTR3A ALDH1A1 2783/4885PREP 3470/4885FAP 2845/4885
US-20230002383-A1 NOVEL FUNCTIONALIZED LACTAMS AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE HTR7, HTR1A, HTR2C ALDH1A1 3128/4885PREP 1513/4885FAP 2775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.